Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NPA CEO Weighs in on CBD, Regulatory Risks

Article-NPA CEO Weighs in on CBD, Regulatory Risks

Fabricant Still
In this video shot at Expo West in Anaheim, California, Daniel Fabricant, Ph.D., of the Natural Products Association weighs in on some of the risks associated with selling CBD in dietary supplements.

At Expo West in Anaheim, California, INSIDER caught up with the head of the Natural Products Association (NPA)—Dr. Daniel Fabricant, Ph.D.—to discuss a wide range of topics impacting marketers and retailers of dietary supplements.

In the first of three short video segments, Dr. Fabricant discusses some of the risks associated with selling a hemp-based compound in supplements that has been all the rage in recent years: CBD or cannabidiol. Check out what the former FDA official has to say about CBD.

 

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish